| Date | Time | Source | Headline | Symbol | Company |
| 05/24/2024 | 7:12PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 05/24/2024 | 7:10PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 05/24/2024 | 7:06PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 05/17/2024 | 7:12PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 05/17/2024 | 7:09PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 05/17/2024 | 7:05PM | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 05/14/2024 | 4:22PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SLRN | ACELYRIN Inc |
| 05/09/2024 | 8:14AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:SLRN | ACELYRIN Inc |
| 05/09/2024 | 8:13AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SLRN | ACELYRIN Inc |
| 05/09/2024 | 8:01AM | GlobeNewswire Inc. | ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones | NASDAQ:SLRN | ACELYRIN Inc |
| 05/09/2024 | 8:00AM | GlobeNewswire Inc. | ACELYRIN, INC. Announces Leadership Transition | NASDAQ:SLRN | ACELYRIN Inc |
| 04/29/2024 | 4:05PM | GlobeNewswire Inc. | ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024 | NASDAQ:SLRN | ACELYRIN Inc |
| 03/28/2024 | 4:05PM | GlobeNewswire Inc. | ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights | NASDAQ:SLRN | ACELYRIN Inc |
| 03/27/2024 | 4:01PM | GlobeNewswire Inc. | Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million | NASDAQ:SLRN | ACELYRIN Inc |
| 03/20/2024 | 7:00AM | GlobeNewswire Inc. | ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease | NASDAQ:SLRN | ACELYRIN Inc |
| 03/11/2024 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SLRN | ACELYRIN Inc |
| 03/11/2024 | 8:02AM | GlobeNewswire Inc. | ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis | NASDAQ:SLRN | ACELYRIN Inc |
| 03/11/2024 | 8:00AM | GlobeNewswire Inc. | ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients | NASDAQ:SLRN | ACELYRIN Inc |
| 02/15/2024 | 4:05PM | GlobeNewswire Inc. | ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications | NASDAQ:SLRN | ACELYRIN Inc |
| 01/12/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN) | NASDAQ:SLRN | ACELYRIN Inc |
| 01/11/2024 | 6:38PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 01/11/2024 | 6:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SLRN | ACELYRIN Inc |
| 01/05/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN) | NASDAQ:SLRN | ACELYRIN Inc |
| 12/20/2023 | 4:38PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SLRN | ACELYRIN Inc |
| 12/20/2023 | 4:30PM | GlobeNewswire Inc. | ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors | NASDAQ:SLRN | ACELYRIN Inc |
| 12/18/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN) | NASDAQ:SLRN | ACELYRIN Inc |
| 12/12/2023 | 8:00AM | PR Newswire (US) | DiCello Levitt LLP Announces Investor Class Action Lawsuit Filed Against Acelyrin, Inc. (NASDAQ: SLRN) and Lead Plaintiff Deadline | NASDAQ:SLRN | ACELYRIN Inc |
| 12/04/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN) | NASDAQ:SLRN | ACELYRIN Inc |
| 11/28/2023 | 6:03AM | IH Market News | Tuesday’s Wall Street Highlights: Zscaler, Shein, 3M, Meta Platforms, and More | NASDAQ:SLRN | ACELYRIN Inc |
| 11/28/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN) | NASDAQ:SLRN | ACELYRIN Inc |